15th Training Course for Minimally Invasive Heart Valve Surgery

15th to 18th September 2024, Innsbruck, Austria.

Focus Valve 2023 was the most successful course in our history.
We were happy to greet more than 260 participants from 40 different countries who were able to watch live surgeries, discuss and interact with masters of minimally invasive and endoscopic valve procedures.

This year we keep our long tradition to provide the scientific community and all surgeons interested in minimally invasive valve surgery with the unedited videos of the live operations which can be found at Focus Valve Live Cases 2023

We also want to stay along with our tradition to support teams who require a more specific hands-on training at a more focused level. For this reason, we offer again a level
2 Wet-lab training during the Focus Valve Training Days 2024, which will be held at our facilities in Innsbruck from February 22nd – 23rd, 2024.
The training will be complemented by intensive OR hospitations and in-depth theoretical presentations. More information about this practical course are available here.

Last but not least, make sure to mark the dates of Focus Valve 2024 which will be held again in Innsbruck from the 15th -18th of September 2024.
For any other requests please feel free to contact us.

General Information

Date: 15th to 18th September 2024

Location: Innsbruck, Austria

For more information and detailed program visit the website.

Published in GI-Mail 02/2024 (English edition).

  • Do you already know our monthly newsletter GI-Mail with useful tips on postgraduate courses?
    Sign up here.
  • Are you looking for vacancies or new career challenges? Here you will find the latest vacancies and job offers.
  • Do you already know our monthly job-information GI-Jobs with current job offers for doctors, managers and nurses? Sign up here.
  • Are you interested in up to date postgraduate courses and CME? In our education database »medicine & health« you will find new education events from over 2300 organizers.




    Comments are closed.